Encompass Health Management

Management criteria checks 3/4

Encompass Health's CEO is Mark Tarr, appointed in Dec 2016, has a tenure of 7.83 years. total yearly compensation is $8.84M, comprised of 11.9% salary and 88.1% bonuses, including company stock and options. directly owns 0.55% of the company’s shares, worth €51.02M. The average tenure of the management team and the board of directors is 11.2 years and 4.8 years respectively.

Key information

Mark Tarr

Chief executive officer

US$8.8m

Total compensation

CEO salary percentage	11.9%
CEO tenure	7.8yrs
CEO ownership	0.6%
Management average tenure	11.2yrs
Board average tenure	4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mark Tarr's remuneration changed compared to Encompass Health's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	US$409m
Mar 31 2024	n/a	n/a	US$387m
Dec 31 2023	US$9m	US$1m	US$362m
Sep 30 2023	n/a	n/a	US$357m
Jun 30 2023	n/a	n/a	US$336m
Mar 31 2023	n/a	n/a	US$280m
Dec 31 2022	US$8m	US$1m	US$256m
Sep 30 2022	n/a	n/a	US$232m
Jun 30 2022	n/a	n/a	US$242m
Mar 31 2022	n/a	n/a	US$253m
Dec 31 2021	US$8m	US$1m	US$298m
Sep 30 2021	n/a	n/a	US$316m
Jun 30 2021	n/a	n/a	US$318m
Mar 31 2021	n/a	n/a	US$304m
Dec 31 2020	US$7m	US$953k	US$193m
Sep 30 2020	n/a	n/a	US$265m
Jun 30 2020	n/a	n/a	US$285m
Mar 31 2020	n/a	n/a	US$342m
Dec 31 2019	US$7m	US$1m	US$358m
Sep 30 2019	n/a	n/a	US$317m
Jun 30 2019	n/a	n/a	US$308m
Mar 31 2019	n/a	n/a	US$309m
Dec 31 2018	US$6m	US$963k	US$290m
Sep 30 2018	n/a	n/a	US$339m
Jun 30 2018	n/a	n/a	US$316m
Mar 31 2018	n/a	n/a	US$288m
Dec 31 2017	US$5m	US$900k	US$271m

Compensation vs Market: Mark's total compensation ($USD8.84M) is above average for companies of similar size in the German market ($USD5.18M).

Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.

CEO

Mark Tarr (62 yo)

7.8yrs

Tenure

US$8,836,376

Compensation

Mr. Mark J. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encompass Health Corp. since December 29, 2016. He s...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Mark Tarr	CEO, President & Director	7.8yrs	US$8.84m	0.55% € 51.0m
Douglas Coltharp	Executive VP & CFO	14.4yrs	US$5.75m	0.26% € 24.1m
Andrew Price	Senior VP & Chief Accounting Officer	15yrs	US$1.10m	0.076% € 7.1m
John Darby	Executive VP	8.7yrs	US$3.17m	0.084% € 7.8m
Elissa Charbonneau	Chief Medical Officer	9.3yrs	US$1.30m	0.018% € 1.7m
Rusty Yeager	Chief Information Officer & Senior VP	13.3yrs	no data	no data
Mark Miller	Senior Vice President of Investor Relations & Strategic Planning	3.1yrs	no data	no data
Dawn Rock	Chief Compliance Officer	9.3yrs	no data	no data
Anthony Hernandez	Chief Human Resources Officer	4.8yrs	no data	no data
Frank Brown	President of Southwest Region	13.1yrs	no data	no data
Jerry Gray	President of West Region	13.1yrs	no data	no data
Peter Mantegazza	President of Northeast Region	16.3yrs	no data	no data

11.2yrs

Average Tenure

60.5yo

Average Age

Experienced Management: HSOA's management team is seasoned and experienced (11.2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Mark Tarr	CEO, President & Director	7.8yrs	US$8.84m	0.55% € 51.0m
Joan Herman	Independent Director	11.8yrs	US$289.80k	0.00099% € 91.7k
Leslye Katz	Independent Director	11.8yrs	US$294.80k	0.00099% € 91.7k
Nancy Schlichting	Independent Director	6.8yrs	US$259.79k	0.000040% € 3.7k
Gregory Carmichael	Independent Chairman	4.8yrs	US$276.01k	0.0038% € 353.0k
Patricia Maryland	Independent Director	4.8yrs	US$256.01k	0.000020% € 1.9k
Christopher Reidy	Independent Director	3yrs	US$272.98k	0.012% € 1.1m
Edward Christie	Director	less than a year	US$74.45k	0.00049% € 45.4k
Kevin O'Connor	Independent Director	2.6yrs	US$252.54k	0.0010% € 93.6k
Terrance Williams	Independent Director	4.8yrs	US$271.01k	0.00035% € 32.4k

4.8yrs

Average Tenure

64.5yo

Average Age

Experienced Board: HSOA's board of directors are considered experienced (4.8 years average tenure).

Encompass Health Management

Management criteria checks 3/4

Key information

Recent management updates

Chief Medical Officer recently sold €783k worth of stock

Encompass Health Corporation, Annual General Meeting, May 02, 2024

Encompass Health Corporation Appoints Andrew Baird as Senior Vice President of Public Policy, Legislation and Regulations

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Chief Medical Officer recently sold €531k worth of stock

Recent updates

Third quarter 2024 earnings released: EPS: US$1.09 (vs US$0.86 in 3Q 2023)

Encompass Health Corporation Raises Earnings Guidance for Full Year 2024

Dividend of US$0.17 announced

Encompass Health Corporation Declares Quarterly Cash Dividend on Common Stock, Payable on January 15, 2025

Encompass Health Corporation to Report Q3, 2024 Results on Oct 28, 2024

Upcoming dividend of US$0.17 per share

Second quarter 2024 earnings released: EPS: US$1.15 (vs US$0.93 in 2Q 2023)

Encompass Health Corporation Raises Earnings Guidance for Full Year 2024

Dividend of US$0.17 announced

Encompass Health Declares Dividend on Common Stock, Payable on October 15, 2024

Encompass Health Corporation to Report Q2, 2024 Results on Aug 05, 2024

Encompass Health Corporation(NYSE:EHC) dropped from Russell Small Cap Comp Growth Index

Chief Medical Officer recently sold €783k worth of stock

First quarter dividend of US$0.15 announced

Encompass Health Declares Dividend on Common Stock, Payable on July 15, 2024

Encompass Health Corporation Provides Earnings Guidance for 2024

First quarter 2024 earnings released: EPS: US$1.14 (vs US$0.89 in 1Q 2023)

Encompass Health Corporation to Report Q1, 2024 Results on Apr 24, 2024

Encompass Health Corporation, Annual General Meeting, May 02, 2024

Encompass Health Corporation Appoints Andrew Baird as Senior Vice President of Public Policy, Legislation and Regulations

Upcoming dividend of US$0.15 per share

Fourth quarter dividend of US$0.15 announced

Full year 2023 earnings released: EPS: US$3.66 (vs US$2.57 in FY 2022)

Encompass Health Corporation Provides Earnings Guidance for the Year 2024

Encompass Health Corporation to Report Q4, 2023 Results on Feb 07, 2024

Upcoming dividend of US$0.15 per share at 0.9% yield

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors

Encompass Health Corporation Revises Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.87 (vs US$0.64 in 3Q 2022)

Encompass Health Corporation to Report Q3, 2023 Results on Oct 26, 2023

Upcoming dividend of US$0.15 per share at 0.9% yield

Chief Medical Officer recently sold €531k worth of stock

Encompass Health Corporation Updates Earnings Guidance for the Full-Year 2023

Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on October 16, 2023

Encompass Health Corporation to Report Q2, 2023 Results on Aug 01, 2023

Upcoming dividend of US$0.15 per share at 0.9% yield

First quarter 2023 earnings released: EPS: US$0.89 (vs US$0.88 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Upcoming dividend of US$0.15 per share at 1.2% yield

Full year 2022 earnings released: EPS: US$2.59 (vs US$4.15 in FY 2021)

Encompass Health Corporation Provides Earnings Guidance for the Full Year 2023

Encompass Health Corporation to Report Q4, 2022 Results on Feb 07, 2023

Upcoming dividend of US$0.15 per share

High number of new directors

Independent Director recently bought €101k worth of stock

Encompass Health Corporation Revises Earnings Guidance for the Year 2022

Third quarter 2022 earnings released: EPS: US$0.64 (vs US$1.01 in 3Q 2021)

Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on January 17, 2023

Encompass Health Corporation to Report Q3, 2022 Results on Oct 26, 2022

Upcoming dividend of US$0.15 per share

Second quarter 2022 earnings released: EPS: US$0.49 (vs US$1.14 in 2Q 2021)

Encompass Health Corporation Affirms Earnings Guidance for the Year 2022

Encompass Health Corporation Declares Dividend on Common Stock, Payable on October 17, 2022

Encompass Health Corporation to Report Q2, 2022 Results on Aug 01, 2022

Upcoming dividend of US$0.28 per share

Investor sentiment deteriorated over the past week

Encompass Health Corporation completed the Spin-Off of Enhabit, Inc. (NYSE:EHAB).

Encompass Health Corporation Revises Earnings Guidance for the Full Year 2022

Insider recently bought €63k worth of stock

Encompass Health Corporation Declares Quarterly Cash Dividend on Common Stock, Payable on July 20, 2022

First quarter 2022 earnings released: EPS: US$0.88 (vs US$1.08 in 1Q 2021)

Encompass Health Corporation Reaffirms Its Revenue Guidance for the Full Year 2022

Encompass Health Corporation, Annual General Meeting, May 05, 2022

Encompass Health Corporation Announces Board Changes

Upcoming dividend of US$0.28 per share

Encompass Health's Home Health Unit Reportedly Attracts Acquisition interest

Encompass Health Corporation Declares Dividend on Common Stock, Payable on April 18, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations